Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Infusion Paclitaxel + Cisplatin and Radiotherapy in Stage III NSCLC
NCT00001499Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and cisplatin in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Primary endpoint: Response Rate. Started Mar 1996; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00001499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001499.